Volume 9, Issue 1 (2024)
SJMR 2024, 9(1): 1-4 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Saremi A. What Should We Do with Negative WBC Cross match after Lymphocyte Therapy?. SJMR 2024; 9 (1) : 1
URL: http://saremjrm.com/article-1-324-en.html
URL: http://saremjrm.com/article-1-324-en.html
Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran. & Sarem Cell Research Center (SCRC), Sarem Women’s Hospital, Tehran, Iran.
Abstract: (530 Views)
Introduction: Cross matching is a way for your healthcare provider to test your blood against a donor's blood to make sure they are fully compatible. It's essentially a trial transfusion done in test tubes to see exactly how your blood will react with potential donor blood. Blood from the donor and recipient are mixed. If the recipient's cells attack and kill the donor cells, the cross match is considered positive. This means the recipient has antibodies "against" the donor's cells. If the cross match is negative, the pair is considered compatible. Certainly! Let's delve deeper into the implications and management considerations when dealing with a negative WBC cross match after lymphocyte therapy in the context of transplantation.
Article number: 1
Article Type: Letter to Editor |
Subject:
Pregnancy Care
Received: 2024/04/21 | Accepted: 2024/05/19 | Published: 2024/12/4
Received: 2024/04/21 | Accepted: 2024/05/19 | Published: 2024/12/4
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
